Medical Affairs Intern - Newark, CA | Biospace
Get Our FREE Industry eNewsletter

Medical Affairs Intern

Depomed, Inc.

Newark, CA
Posted Date:
Position Type:
Full time
Job Code:
Required Education:
Medical Doctor
Areas of Expertise Desired:

Job Description

City Newark
State California [CA]
Title Medical Affairs Intern
Job ID 898XX
Date Added 3/7/2017
Department Medical Affairs


Depomed’s Medical Affairs Summer internship provides a time and access to the people in a hands on approach to delve deeply into many areas a scientist entering a pharma/biotech company would gain exposure from. The medical affairs function serves to bridge the gap from late stage drug development to commercialization of a drug through its full lifecycle on the market. We work on cross-functional teams on a daily basis including Clinical Affairs, Marketing, Sales, Managed markets, and even with external HCPs and customers. You would be working with us to effect change.

•Support the development and updating of standard response letter documents as they pertain to medical information letters and FAQs including linking and annotating reference to the their supported statement.
•Fact check promotional materials against specific references as provided.
•Provide support in review/editing company manuscripts for both marketed and development agents.
•Support the creation of scientific and medical content for product level training internally and externally.
•Provide support in coordinating medical initiatives or projects.
•Able to lead or co-lead projects in MA and potential cross-functional initiatives
•Potentially many other areas to aid the Medical Affairs, PV, clinical and R&D organization as a whole depending on experience and needs.

•Aid in support and coordination of the Investigator Initiated Research program and Medical Education Grant Program and related processes
•Work with cross-functional partners, i.e. Clinical Affairs, Marketing Managed Markets.
•Depending on duration of assignment, may be assigned to various departments on a rotating basis.


•PharmD/PhD/MD or advanced healthcare degree or in last 2 years of completion or current fellowship.
•Research Experience preferred but not required

•Self-motivated, adaptable to a dynamic environment
•Must be a hard worker with a strong sense of attention to detail and be able to prioritize and handle multiple tasks simultaneously
•Excellent organization and planning skills
•Scientific & Medical terminology acumen
•Strong interpersonal skills and communication skills (both written and oral)
•Able to collaborate effectively with cross-functional team members
•Proficiency in MS Outlook, Word, Excel and PowerPoint, database management

•Decisions & Judgment
•Ownership & Initiative
•Adaptability & Change Readiness
•Teamwork & Collaboration

•Sitting: 75%
•Standing/ walking: 25%

Additional information:
The summer internship is an 8-10 week full time paid internship.

Location on internship:
This position will be located at Depomed’s home office at:
7999 Gateway Blvd, Suite 300
Newark, CA 94560

*Candidates applying for the position must find their own housing for the duration of their internship

About Us

Depomed, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. Founded in 1995, Depomed has successfully executed on strategy of acquiring, integrating and growing differentiated therapeutic products and building each into a strong market presence. The result is a broad portfolio of pain and neurology specialty pharmaceuticals currently comprised of five FDA-approved products. These include Gralise® for the management of Postherpetic Neuralgia (PHN), Cambia® for the acute treatment of migraine attacks, Zipsor® for the relief of mild to moderate acute pain, Lazanda® for the management of breakthrough pain in cancer patients and our most recent addition, the company’s flagship asset, the NUCYNTA® franchise.

Acquired in April 2015 and re-launched in June 2015, the NUCYNTA franchise includes NUCYNTA® ER for the extended management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) and NUCYNTA® for immediate management of moderate to severe acute pain in adults.

Depomed also has successfully developed and licensed its unique drug-delivery technology, Acuform®. This patented oral-delivery technology allows for the targeted, extended release of pharmaceutical compounds into the upper gastrointestinal tract. The company’s Acuform technology is currently being used in four marketed drugs, including Gralise.

Depomed’s successful execution on strategy and has resulted in solid product revenue growth over the past three years. Located in Newark, California in the East Bay of San Francisco, Depomed is listed on the NASDAQ market under the ticker DEPO and employs approximately 500 people, of which approximately 350 are part of the Commercial organization.